ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

AACI’s “12 Tasks” Outlined to Board

March 28, 1975

In Brief: NCI Terminates Straus’ Grant Following Site Visit Report Charging “Lack Of satisfactory Progress

February 19, 1982

In Brief: Big Ten Cancer Research Consortium Names Executive Officer

May 30, 2014

12 Minority CCOPs Awardees Names, San Antonio Gets 2

September 21, 1990

In Brief: Senate Health Subcommittee Lineup Completed; GAO Calls For More Ionizing Radiation Studies

January 23, 1981